News

PlaqueIQ is the first and only FDA-cleared, non-invasive plaque analysis based on objective histology. PlaqueIQ delivers automated quantification and classification of plaque morphology, and is ...
Zetia keeps your body from absorbing cholesterol in your diet, and it is generally safe and well-tolerated. So, it’s a good ...
A substudy reports that optical coherence tomography resulted in less vessel failure after percutaneous coronary angioplasty ...
A new study published in the Journal of American Medical Association showed no advantage to immediate coronary angiography ...
A Mumbai hospital has successfully performed a rare and intricate heart surgery on an 18-month-old child diagnosed with a ...
The Golden Hour is the 60 minutes following the onset of a heart attack. Doctors say this is an extremely crucial period, as ...
EviCore’s updated coverage guidelines support access to AI-enabled Plaque Analysis to help physicians precisely diagnose and manage patients with coronary artery diseaseMOUNTAIN VIEW, Calif., July 11, ...
I am a 64-year-old man who has been having periodic shortness of breath for the past six months or so. This happens mostly ...
This case is unique because it documents a rare occurrence of a Type IV stent fracture following percutaneous coronary ...
Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive ...
The history, ECG, age, risk factors, and troponin (HEART) score was developed as a rapid risk stratification tool. It has ...
June 30, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced ... over half of patients beyond coronary computed tomography ...